Dashwood, A., Makuyana, N., Kant, R. v. d., Ghodsinia, A., Hernandez, A. R., Lienart, S., . . . Liston, A. Directed disruption of IL2 aggregation and receptor binding sites produces designer biologics with enhanced specificity and improved production capacity. Elsevier.
Chicago Style (17th ed.) CitationDashwood, Amy, et al. Directed Disruption of IL2 Aggregation and Receptor Binding Sites Produces Designer Biologics with Enhanced Specificity and Improved Production Capacity. Elsevier.
MLA (9th ed.) CitationDashwood, Amy, et al. Directed Disruption of IL2 Aggregation and Receptor Binding Sites Produces Designer Biologics with Enhanced Specificity and Improved Production Capacity. Elsevier.
Warning: These citations may not always be 100% accurate.